Dimensional Fund Advisors LP Reduces Stock Position in Semler Scientific, Inc. (NASDAQ:SMLR)

Dimensional Fund Advisors LP trimmed its stake in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 18.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 150,327 shares of the company’s stock after selling 34,955 shares during the period. Dimensional Fund Advisors LP’s holdings in Semler Scientific were worth $8,119,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of SMLR. Capital International Investors acquired a new stake in Semler Scientific in the fourth quarter valued at $30,813,000. Thames Capital Management LLC purchased a new stake in shares of Semler Scientific in the 4th quarter worth about $6,465,000. Invesco Ltd. acquired a new stake in Semler Scientific in the 4th quarter valued at about $5,964,000. Principal Financial Group Inc. increased its holdings in Semler Scientific by 633.1% during the 4th quarter. Principal Financial Group Inc. now owns 112,487 shares of the company’s stock valued at $6,074,000 after acquiring an additional 97,144 shares in the last quarter. Finally, Wells Fargo & Company MN raised its position in Semler Scientific by 618.3% during the fourth quarter. Wells Fargo & Company MN now owns 103,465 shares of the company’s stock worth $5,587,000 after acquiring an additional 89,060 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Performance

Semler Scientific stock opened at $34.79 on Friday. Semler Scientific, Inc. has a fifty-two week low of $21.77 and a fifty-two week high of $81.56. The company has a market capitalization of $333.88 million, a price-to-earnings ratio of 7.09 and a beta of 1.33. The stock has a fifty day moving average of $35.05 and a two-hundred day moving average of $46.60.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, topping analysts’ consensus estimates of $0.20 by $3.21. The firm had revenue of $12.41 million during the quarter. Semler Scientific had a return on equity of 50.77% and a net margin of 72.65%.

Analysts Set New Price Targets

Separately, Lake Street Capital increased their price target on shares of Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday, January 24th.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.